1. Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D. REACH Registry Investigators. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry. Vasc Med. 2010;15(4):259–65. doi: 10.1177/1358863X10373299.
2. Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E et al. European Society of Cardiology Working Group on peripheral circulation. Non-coronary atherosclerosis. Eur Heart J. 2014;35(17):1112–9. doi: 10.1093/eurheartj/ehu071.
3. van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM. SMART Study Group. The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients. Eur J Clin Invest. 2014;44(3):231–9. doi: 10.1111/eci.12222.
4. Барбараш Л. С., Сумин А. Н. Диагностика ИБС перед операциями на некоронарных сосудистых бассейнах. Ангиология и сосудистая хирургия. 2016;22(2):188–196..
5. Найден Т. В., Бартош-Зеленая С. Ю., Плавинский С. Л., Евсикова И. А. Предикторы изолированных и сочетанных атеросклеротических поражений на субклинической стадии у мужчин среднего возраста и их взаимосвязь с метаболическим синдромом. Артериальная гипертензия. 2017; 23(1):56–68..
6. McCully KS. Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol. 2015;8(2):211–9. doi: 10.1586/17512433.2015.1010516.
7. Tanaka S, Kaneko H, Kano H, Matsuno S, Suzuki S, Takai H et al. The predictive value of the borderline anklebrachial index for long-term clinical outcomes: an observational cohort study. Atherosclerosis. 2016;250:69–76. doi: 10.1016/j. atherosclerosis.2016.05.014.
8. Cecere A, Riccioni G, Sforza N, Marano R, Guglielmi G. Coronary artery calcium score and coronary computed tomography angiography for patients with asymptomatic polyvascular (non-coronary) atherosclerosis. Singapore Med J. 2016. doi: 10.11622/smedj.2016186..
9. Корок Е. В., Сумин А. Н., Синьков М. А., Нагирняк О. А., Чичкова Т. Ю., Барбараш Л. С. Частота выявления интактных коронарных артерий в зависимости от показаний для плановой коронарной ангиографии. Российский кардиологический журнал. 2016;2(130):52–59. DOI: http://dx.doi. org/10.15829/1560–4071–2016–2-52–59.
10. Patel MR, Dai D, Hernandez AF, Douglas PS, Messenger J, Garratt KN et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J. 2014;167(6):846–852. doi:10.1016/j.ahj.2014.03.001.
11. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.
12. Smeeth L, Skinner JS, Ashcroft J, Hemingway H, Timmis A. Chest Pain Guideline Development Group. Chest Pain Guideline Development Group. NICE clinical guideline: chest pain of recent onset. Br J Gen Pract. 2010;60(577):607–10. doi: 10.3399/bjgp10X515124.
13. Neglia D, Rovai D, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S et al. EVINCI Study Investigators. Detection of significant coronary artery disease by non-invasive anatomical and functional imaging. Circ Cardiovas Imaging. 2015;8(3): e002179.
14. Lee H, Yoon YE, Park JB, Kim HL, Park HE, Lee SP et al. The incremental prognostic value of cardiac computed tomography in comparison with single-photon emission computed tomography in patients with suspected coronary artery disease. PLoS One. 2016;11(8):e0160188. doi: 10.1371/journal.pone.0160188.
